See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2020_Vyant_Bio_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.0021560328994649843, 'aggregate_val': 12496000, 'exp_sum': 12523000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 3701000, 'GeneralAndAdministrativeExpense': 5171000, 'GoodwillImpairmentLoss': 2900000, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 1146000, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -395000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.32475534613990575, 'aggregate_val': 14904000, 'exp_sum': 22072000, 'exp_to_value': {'IntangibleAssets': 5985000, 'AssetsNonCurrent': 7168000, 'AssetsCurrent': 7178000, 'PropertyPlantAndEquipment': 558000, 'remainder_Assets': 1183000}} |
Graph
Absolute values for 0001349929, Vyant Bio Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 5,985,000 |
| 1 | AssetsNonCurrent | 7,168,000 |
| 2 | AssetsCurrent | 7,178,000 |
| 3 | PropertyPlantAndEquipment | 558,000 |
| 4 | remainder_Assets | -5,985,000 |
| 5 | LongTermLiabilities | 10,000 |
| 6 | LiabilitiesCurrent | 6,972,000 |
| 7 | remainder_Liabilities | 537,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 3,701,000 |
| 10 | GeneralAndAdministrativeExpense | 5,171,000 |
| 11 | GoodwillImpairmentLoss | 2,900,000 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 1,146,000 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -422,000 |
| 17 | remainder_Revenues | 7,305,000 |
| 18 | remainder_NetIncome | -1,517,000 |
| 19 | remainder_ComprehensiveNetIncome | -34,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 14,904,000 |
| 1 | Liabilities | 7,519,000 |
| 2 | Expenses | 12,496,000 |
| 3 | Revenues | 7,305,000 |
| 4 | StockholdersEquity | 7,385,000 |
| 5 | NetIncome | -6,708,000 |
| 6 | ComprehensiveNetIncome | -6,742,000 |
| 7 | BaseVar | 25,410,580 |
| 8 | EconomicCapitalRatio | 0.313 |
Edgar->Model Mapping
Feature Distribution
Change over Time
